Prevention of microvascular complications in diabetic children and adolescents

被引:3
|
作者
Verrotti, A [1 ]
Catino, M [1 ]
Di Ricco, L [1 ]
Casani, A [1 ]
Chiarelli, F [1 ]
机构
[1] Univ G dAnnunzio, Osped Policlin, Dept Pediat, I-66100 Chieti, Italy
关键词
diabetes; microvascular complications; nephropathy; retinopathy;
D O I
10.1111/j.1651-2227.1999.tb14338.x
中图分类号
R72 [儿科学];
学科分类号
100202 ;
摘要
Diabetes mellitus causes profound alterations in many body tissues. Microvascular diabetic complications include diabetic neuropathy, nephropathy and retinopathy. Nephropathy first becomes manifest with hyperfiltration and microalbuminuria. These functional changes evolve over several years to a stage of marked deterioration of renal function. The possible preventive measures are metabolic control, reduction of dietary protein intake and use of ACE-inhibitors. Metabolic control is also important for the prevention of diabetic retinopathy. In fact, patients with HbA1c higher than 10% have an increased risk of progression of retinopathy. Moreover, an accelerated progression of retinopathy has been observed in patients with systemic hypertension following the onset of microalbuminuria. It has been demonstrated that diabetic neuropathy can also be present during childhood; therefore, it is possible to detect electrophysiological abnormalities in children and adolescents with IDDM. Glycaemic and blood pressure control are, so far, the main means for possible prevention or modification of the natural history of diabetic microvascular complications. Tight glycaemic control may have beneficial effects for diabetic neuropathy. In addition, other preventive measures, such as aldose reductase inhibitors, gangliosides, neurotrophic vitamins, etc., have been studied in the last years. However, no conclusive results have been obtained so far.
引用
下载
收藏
页码:35 / 38
页数:4
相关论文
共 50 条
  • [31] Coconut phytocompounds inhibits polyol pathway enzymes: Implication in prevention of microvascular diabetic complications
    Sheela, Devi Lekshmi
    Nazeem, Puthiyaveetil Abdulla
    Narayanankutty, Arunaksharan
    Shylaja, R. Muthangaparambil
    Davis, Sangeetha P.
    James, Priyanga
    Valsalan, Ravisankar
    Babu, Thekkekara Devassy
    Raghavamenon, Achuthan C.
    PROSTAGLANDINS LEUKOTRIENES AND ESSENTIAL FATTY ACIDS, 2017, 127 : 20 - 24
  • [32] miRNAs as cornerstones in diabetic microvascular complications
    Ismail, Ahmed
    El-Mahdy, Hesham A.
    Eldeib, Mahmoud Gomaa
    Doghish, Ahmed S.
    MOLECULAR GENETICS AND METABOLISM, 2023, 138 (01)
  • [33] Aldose reductase in diabetic microvascular complications
    Chung, SSM
    Chung, SK
    CURRENT DRUG TARGETS, 2005, 6 (04) : 475 - 486
  • [34] HIGH INCIDENCE OF EARLY MICROVASCULAR COMPLICATIONS IN A COHORT OF HAITIAN CHILDREN AND ADOLESCENTS WITH DIABETES
    Robinson, Marie-Eve
    Carolan, Eirin
    Sainvil, Michele
    Altenor, Kelty
    Carpenter, Christopher
    Bonnell, Ric
    Lorgeat, Viviane
    Von Oettingen, Julia
    HORMONE RESEARCH IN PAEDIATRICS, 2017, 88 : 417 - 417
  • [35] Microvascular complications in children and adolescents with type 1 diabetes mellitus in Assiut governorate, Egypt
    Kamaleldeen, Eman B.
    Mohammad, Hanaa A.
    Mohamed, Ebtsam F.
    Askar, Ahmed G.
    EGYPTIAN PEDIATRIC ASSOCIATION GAZETTE, 2018, 66 (04) : 85 - 90
  • [36] ISPAD Clinical Practice Consensus Guidelines 2018: Microvascular and macrovascular complications in children and adolescents
    Donaghue, Kim C.
    Marcovecchio, M. Loredana
    Wadwa, R. P.
    Chew, Emily Y.
    Wong, Tien Y.
    Calliari, Luis Eduardo
    Zabeen, Bedowra
    Salem, Mona A.
    Craig, Maria E.
    PEDIATRIC DIABETES, 2018, 19 : 262 - 274
  • [37] DIABETIC COMPLICATIONS AND THEIR PREVENTION OR REVERSAL
    DANOWSKI, TS
    OHLSEN, P
    FISHER, ER
    DIABETES CARE, 1980, 3 (01) : 94 - 99
  • [38] Prevention of diabetic foot complications
    Nather, Aziz
    Cao, Shuo
    Chen, Jamie Li Wen
    Low, An Yee
    SINGAPORE MEDICAL JOURNAL, 2018, 59 (06) : 291 - 294
  • [39] PREVENTION OF DIABETIC FOOT COMPLICATIONS
    LITZELMAN, DK
    SLEMENDA, CW
    LANGEFELD, CD
    VINICOR, F
    CLINICAL RESEARCH, 1990, 38 (02): : A717 - A717
  • [40] PREVENTION AND TREATMENT OF DIABETIC COMPLICATIONS
    LEVIN, ME
    BONIUK, I
    ANDERSON, CB
    AVIOLI, LV
    ARCHIVES OF INTERNAL MEDICINE, 1980, 140 (05) : 691 - 696